Massimiliano Todisco

Medicine & Life Sciences

1. Normal Pressure Hydrocephalus 100%
2. Parkinsonian Disorders 49%
3. Dopamine Plasma Membrane Transport Proteins 37%
4. Deglutition Disorders 37%
5. Corpus Striatum 36%
6. Deglutition 34%
7. Parkinson Disease 28%
8. Gait 28%
9. SARS Virus 24%
10. Multiple System Atrophy 19%
11. Coronavirus 18%
12. Smell 17%
13. Matrix Metalloproteinase 2 16%
14. Reaction Time 14%
15. Phenotype 13%
16. Brain 13%
17. Matrix Metalloproteinase 9 13%
18. Dopamine 12%
19. Neurological Rehabilitation 12%
20. Tissue Inhibitor of Metalloproteinase-1 12%
21. Myoclonic dystonia 12%
22. Transcranial Direct Current Stimulation 12%
23. Levodopa 11%
24. Vocal Cords 11%
25. Prospective Studies 11%
26. Systematic Reviews 11%
27. Magnetic Resonance Imaging 11%
28. Chronic Inflammatory Demyelinating Polyradiculoneuropathy 10%
29. Aquaporin 4 10%
30. Progressive Supranuclear Palsy 10%
31. Tissue Inhibitor of Metalloproteinase-2 9%
32. Tissue Inhibitor of Metalloproteinases 9%
33. White Matter 9%
34. Dysphonia 9%
35. Single-Photon Emission-Computed Tomography 9%
36. 2-carbomethoxy-8-(3-fluoropropyl)-3-(4-iodophenyl)tropane 9%
37. Nortropanes 8%
38. Myasthenia Gravis 8%
39. Cerebrospinal Fluid 8%
40. Blinking 8%
41. Anal Canal 8%
42. Respiratory Sounds 8%
43. Neurology 7%
44. Electromyography 7%
45. Neuronal Plasticity 7%
46. Coronavirus Infections 6%
47. Autoantibodies 6%
48. Dystonic Disorders 6%
49. Movement Disorders 6%
50. Severe Acute Respiratory Syndrome 6%